Tower Research Capital LLC (Trc) Alx Oncology Holdings Inc Transaction History

Tower Research Capital LLC (Trc)

$4.87 Billion
Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,001 shares of ALXO stock, worth $5,501. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,001

Previous 7,347 31.93%

Holding current value

$5,501

Previous $13,000 38.46%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$1.21 - $1.87 $2,838 - $4,387	-2,346 Reduced 31.93%	5,001 $8,000
Q3 2024 Nov 14, 2024	SELL	$1.81 - $8.13 $419 - $1,886	-232 Reduced 3.06%	7,347 $13,000
Q2 2024 Aug 13, 2024	BUY	$5.84 - $17.56 $16,544 - $49,747	2,833 Added 59.69%	7,579 $45,000
Q1 2024 May 15, 2024	SELL	$10.95 - $16.79 $30,824 - $47,263	-2,815 Reduced 37.23%	4,746 $52,000
Q4 2023 Feb 13, 2024	BUY	$4.81 - $15.38 $19,817 - $63,365	4,120 Added 119.73%	7,561 $112,000
Q3 2023 Nov 14, 2023	BUY	$4.19 - $7.35 $4,885 - $8,570	1,166 Added 51.25%	3,441 $16,000
Q2 2023 Aug 14, 2023	SELL	$4.37 - $9.56 $49,901 - $109,165	-11,419 Reduced 83.39%	2,275 $17,000
Q1 2023 May 09, 2023	BUY	$4.52 - $11.71 $56,377 - $146,058	12,473 Added 1021.54%	13,694 $62,000
Q4 2022 Feb 10, 2023	SELL	$9.51 - $12.95 $75,880 - $103,328	-7,979 Reduced 86.73%	1,221 $13,000
Q3 2022 Nov 10, 2022	BUY	$8.23 - $15.14 $17,365 - $31,945	2,110 Added 29.76%	9,200 $88,000
Q2 2022 Aug 15, 2022	BUY	$5.89 - $19.46 $24,891 - $82,237	4,226 Added 147.56%	7,090 $57,000
Q1 2022 May 12, 2022	SELL	$13.65 - $22.06 $19,287 - $31,170	-1,413 Reduced 33.04%	2,864 $48,000
Q4 2021 Feb 14, 2022	BUY	$21.49 - $74.4 $61,289 - $212,188	2,852 Added 200.14%	4,277 $92,000
Q3 2021 Nov 15, 2021	SELL	$52.51 - $80.91 $10,764 - $16,586	-205 Reduced 12.58%	1,425 $105,000
Q2 2021 Aug 16, 2021	BUY	$52.2 - $75.23 $45,361 - $65,374	869 Added 114.19%	1,630 $89,000
Q1 2021 May 17, 2021	SELL	$62.84 - $87.68 $38,458 - $53,660	-612 Reduced 44.57%	761 $56,000
Q4 2020 Feb 16, 2021	SELL	$34.11 - $112.26 $7,163 - $23,574	-210 Reduced 13.27%	1,373 $118,000
Q3 2020 Nov 16, 2020	BUY	$29.36 - $47.1 $46,476 - $74,559	1,583 New	1,583 $60,000

Others Institutions Holding ALXO

# of Institutions

Shares Held

39.5M

Call Options Held

213K

Put Options Held

44.8K

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $44.8M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Alx Oncology Holdings Inc Transaction History